U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07286682) titled 'A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants' on Dec. 03.

Brief Summary: The purpose of this study is to evaluate the safety and tolerability of single ascending doses of UCB5285 in healthy study participants, including healthy Japanese study participants

Study Start Date: Dec. 08

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: UCB5285

Participants will receive UCB5285 as prespecified in each cohort.

OTHER: Placebo

Participants will receive matching placebo as prespecified in each cohort.

Recruitment Status: NOT_YET_RECRUITING...